Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases.
Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases.
复制标题
HSP gp96 诱导 Foxp3 并激活 Tregs 治疗自身免疫性疾病
DOI:
10.1016/j.isci.2021.103445
复制
发表时间:
2021-12-17
期刊:
影响因子:
5.8
通讯作者:
Meng S
中科院分区:
文献类型:
--
作者:
Xu Y;Liu E;Xie X;Wang J;Zheng H;Ju Y;Chen L;Li C;Zhou X;Li Z;Li X;Meng S
Upregulation and stabilization of Foxp3 expression in Tregs are essential for regulating Treg function and immune homeostasis. In this study, gp96 immunization showed obvious therapeutic effects in a Lyn–/– mouse model of systemic lupus erythematosus. Moreover, gp96 alleviated the initiation and progression of MOG-induced experimental autoimmune encephalomyelitis. Immunization of gp96 increased Treg frequency, expansion, and suppressive function. Gene expression profiling identified the NF-κB family member p65 and c-Rel as the key transcription factors for enhanced Foxp3 expression in Treg by gp96. Mutant gp96 within its Toll-like receptor (TLR) binding domain, TLR2 knockout mice, and mice with cell-specific deletion of MyD88, were used to demonstrate that gp96 activated Tregs and induced Foxp3 expression via a TLR2-MyD88-mediated NF-κB signaling pathway. Taken together, these results show that gp96 immunization restricted antibody-induced and Th-induced autoimmune diseases by integrating Treg expansion and activation, indicating its potential clinical usefulness against autoimmune diseases. SLE symptoms in Lyn–/– mice are ameliorated by gp96 immunization Tregs expanded by gp96 provide potential in suppressing Th-mediated EAE Gp96 promotes Treg proliferation, stability, and suppressive function Gp96 binds to and activates Treg in a TLR2-MyD88-NF-кB-Foxp3 pathway Immune response, Genomics, Molecular biology
登录
查看更多内容
影响因子:
30.5
作者:
Kitagawa Y;Ohkura N;Kidani Y;Vandenbon A;Hirota K;Kawakami R;Yasuda K;Motooka D;Nakamura S;Kondo M;Taniuchi I;Kohwi-Shigematsu T;Sakaguchi S
通讯作者:
Sakaguchi S
影响因子:
64.5
作者:
Feng Y;Arvey A;Chinen T;van der Veeken J;Gasteiger G;Rudensky AY
通讯作者:
Rudensky AY
影响因子:
32.4
作者:
Morita H;Arae K;Unno H;Miyauchi K;Toyama S;Nambu A;Oboki K;Ohno T;Motomura K;Matsuda A;Yamaguchi S;Narushima S;Kajiwara N;Iikura M;Suto H;McKenzie AN;Takahashi T;Karasuyama H;Okumura K;Azuma M;Moro K;Akdis CA;Galli SJ;Koyasu S;Kubo M;Sudo K;Saito H;Matsumoto K;Nakae S
通讯作者:
Nakae S
影响因子:
3.7
作者:
Liu W;Chen M;Li X;Zhao B;Hou J;Zheng H;Qiu L;Li Z;Meng S
通讯作者:
Meng S
DOI:
10.20900/immunometab20200019
发表时间:
2020-01-01
期刊:
Immunometabolism
影响因子:
--
作者:
Hayes, Colleen E;Ntambi, James M
通讯作者:
Ntambi, James M